Article info

Download PDFPDF
Concise report
Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study

Authors

  1. Correspondence to Dr Juan J Gomez-Reino, Department of Rheumatology Unit, Hospital Clinico Universitario, Santiago de Compostela, Santiago, Spain; juan.jesus.gomez-reino.carnota{at}sergas.es
View Full Text

Citation

Gomez-Reino JJ, Maneiro JR, Ruiz J, et al
Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study

Publication history

  • Received January 11, 2012
  • Accepted May 31, 2012
  • First published June 26, 2012.
Online issue publication 
October 05, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.